Central Data Catalog
Citation Information
| Type | Journal Article - Lancet |
| Title | PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial |
| Author(s) | |
| Volume | 376 |
| Issue | 9749 |
| Publication (Day/Month/Year) | 2010 |
| Page numbers | 1329-1337 |
| URL | http://www.ncbi.nlm.nih.gov/pubmed/?term=PRO2000+vaginal+gel+for+prevention+of+HIV-1+infection+(Microbicides+Development+Programme+301):+a+phase+3,+randomised,+double-blind,+parallel-group+trial |
McCormack, Sheena, Gita Ramjee, Anatoli Kamali, Helen Rees, Angela M Crook, Mitzy Gafos, Ute Jentsch, Robert Pool, Maureen Chisembele, Saidi Kapiga, Richard Mutemwa, Andrew Vallely, Thesla Palanee, Yuki Sookrajh, Charles J Lacey, Janet Darbyshire, Heiner Grosskurth, Albert Profy, Andrew Nunn, Richard Hayes, and Jonathan Weber. "PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial." Lancet 376, no. 9749 (2010): 1329-1337.
